PIK90 has been shown in previous studies to significantly attenuate CXCL12‐induced chemotaxis and actin polymerisation, while also demonstrating efficacy in inducing apoptosis in chronic lymphocytic leukaemia cells [39]. This evidence concerns the gene CXCL12 and B-cell chronic lymphocytic leukemia.